The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.

Merck is expanding its pipeline and portfolio of cardio-pulmonary disease treatments by acquiring Verona Pharma plc.

RAHWAY, N.J. - Pharmaceutical giant Merck (NYSE:MRK), with a market capitalization of $203 billion and impressive 77% gross profit margin, will present new data from its HIV research pipeline at ...

Merck's U.S. headquarters are in Rahway, New Jersey. When asked whether the company had plans to reduce its workforce at any of its other sites in Pennsylvania, Merck released a statement that ...

See the latest Merck & Co Inc stock price (MRK:XNYS), related news, valuation, dividends and more to help you make your investing decisions.

US-based Merck said the app known as map4health was developed as an extension of Journey for Control. This collaboration between patient engagement programme Healthy Interactions and Merck began ...

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion. The acquisition – which was confirmed to be in the final stages ...

Review the current Merck & Co Inc (MRK:XNYS) dividend yield and history to decide if MRK is the best investment for you.

Merck is acquiring UK-based Verona Pharma for about $10 billion, as part of the U.S. drugmaker's strategy to diversify beyond its blockbuster cancer treatment Keytruda. Merck shells out $10 ...

View the latest Merck KGaA (MRK) stock price, news, historical charts, analyst ratings and financial information from WSJ.